PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy

por Yousefnezhad, Mina, Davaran, Soodabeh, Babazadeh, Mirzaagha, Akbarzadeh, Abolfazl, Pazoki-Toroudi, Hamidreza
Publicado 2023